Cancer stem cells (CSCs) are a subpopulation with the properties of extensive selfrenewal, capability to generate differentiated cancer cells and resistance to therapies.
epithelial cellular markers. The use of CytoMatrix to study CSCs subpopulation confirms that SCD1 protein expression is enhanced in 3D spheroids when compared with 2D adherent cell cultures. YAP/TAZ nuclear-cytoplasmic distribution analysed by CytoMatrix in 3D spheroids is highly heterogeneous and faithfully reproduces what is observed in tumour biopsies. Our results confirm and extend the robustness of our workflow for the isolation and phenotypic characterization of primary cancer cells derived from the lung MPEs and underscore the role of SCD1.
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| INTRODUCTION
Lung cancer is the most common cause of cancer deaths.
Approximately 85% of those cases are classified as non-small-cell lung cancer (NSCLC), of which adenocarcinoma is the most common histological subtype. Despite advances in anticancer therapies, the 5-year survival rate (17.8%) for NSCLC is much lower than that of other leading cancers (Ettinger et al., 2017; Ferlay et al., 2015; Siegel, Miller, & Jemal, 2018) .
For decades, the gold standard therapy for NSCLC patients in the first-line setting has been platinum-based doublet chemotherapy with targeted agents limited to a subset of patients with specific genetic alterations such as epidermal growth factor receptor mutations or anaplastic lymphoma kinase (ALK) and reactive oxygen species (ROS) translocations, and concomitant development of strategies for undruggable targets such as KRAS mutations (Acunzo et al., 2017; Reck et al., 2014) . The recent introduction of immunotherapy with immune checkpoint inhibitors (ICI) directed against targets such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and PD-1/programmed death-ligand 1 (PDL1) is rapidly changing standard treatments for NSCLC patients as well as for several other advanced malignancies (Callahan, Postow, & Wolchok, 2016; Herbst et al., 2016; Reck et al., 2016) . However, it is important to point out that the use of both cisplatin and ICI therapy results in an unfavourable outcome for a substantial proportion of patients due to drug resistance (Goss & Tsvetkova, 2012; Ilie et al., 2017) .
A growing body of evidence suggests that treatment failures in patients with NSCLC can be attributed to the presence of a subpopulation of cancer cells with distinctive features, defined as cancer stem cells (CSCs) (Lopez-Ayllon et al., 2014; Zhang et al., 2016) .
These cells are characterized by the ability to self-renew (Plaks, Kong, & Werb, 2015; Reya, Morrison, Clarke, & Weissman, 2001; Shackleton, Quintana, Fearon, & Morrison, 2009) . CSCs, for their intrinsic stem-like properties, seem to be responsible for the development of resistance to anticancer treatments such as conventional chemotherapy, radiation, and targeted therapies (Abdullah & Chow, 2013; Mihanfar et al., 2018; Pisanu et al., 2018; Yakisich, Azad, Kaushik, & Iyer, 2017) . In contrast, growing evidence suggest that CSCs are by themselves weakly immunogenic and are not efficiently recognized and eliminated by the immune system. In addition, CSCs have been postulated to foster the creation of an immune-evading microenvironment, which is emerging as a critical element in limiting the efficacy of ICI therapy (Codd, Kanaseki, Torigo, & Tabi, 2018; Sultan et al., 2017) .
One of the main difficulties consists in the isolation of CSCs, given their poor abundance in the tumour tissue, their slow replication kinetics, their plasticity and phenotypic heterogeneity (Grimshaw et al., 2008; Ricci-Vitiani et al., 2006) . Even though several methods for isolating, propagating and characterizing CSCs have been developed (Collins, Berry, Hyde, Stower, & Maitland, 2005; Eramo et al., 2007; Grimshaw et al., 2008; Hemmati et al., 2003; Ricci-Vitiani et al., 2006) , there is still the need to develop robust and reproducible protocols. In recent years, we and others have reported that malignant pleural effusions (MPEs) could represent an excellent model to investigate tumour heterogeneity and to isolate putative CSCs, based on the rationale that it is an easily accessible form of metastatic malignancy (Basak et al., 2009; Giarnieri et al., 2013 Giarnieri et al., , 2015 Mancini et al., 2011; Roscilli et al., 2016; Tiran et al., 2017) . MPEs, defined as pleural fluid containing malignant cells, are a complication caused by primary malignant pleural mesothelioma or by metastatic cancers originating, most commonly, from the lung and breast. MPE occurrence is observed in about 30% of lung cancer cases and is associated with poor prognosis (Penz, Watt, Hergott, Rahman, & Psallidas, 2017) . Among several techniques proposed to isolate and enrich CSCs, many evidence support the concept that cell cultures in nonadherent conditions and in a serumfree medium supplemented with growth factors promote the formation of spheroids with stem-like properties (Eramo et al., 2007; Grimshaw et al., 2008; Mancini et al., 2011) .
We previously reported a protocol to establish MPE-derived tumour cell cultures from NSCLC patients. These cells can be grown in nonadherent conditions as three-dimensional (3D) spheroids enriched for stem-like properties, including upregulation of aldehyde dehydrogenase (ALDH) activity, nanog, oct4 and sox2 markers, and give rise efficiently to tumours, which reproduce the same histological features of the original human tumour, when implanted in recipient mice (Mancini et al., 2011) . Lung cancer 3D spheroids overexpress genes involved in lipid metabolism. Among them we identified stearoyl-CoA desaturase 1 (SCD1), the main biosynthetic enzyme responsible for the conversion of saturated fatty acids into monounsaturated fatty acids, as a key factor for lung CSCs and showed that its inhibition reverts resistance to cisplatin treatment acting synergistically with chemotherapy Pisanu et al., 2017) . At a mechanistic level, SCD1 inhibition inactivates β-catenin and Yes-associated protein/transcriptional coactivator with PDZ-binding motif (YAP/TAZ) signalling pathways involved in the maintenance of the CSCs pool . We also used primary MPE-derived tumour cultures as a tool for screening sensitivity to chemotherapeutic agents and for genetic profiling, to select the most effective therapy regimen (Roscilli et al., 2016) .
Over the last 5 years we have been able to collect and analyze in our laboratory more than 300 MPE-derived NSCLC samples. Of these, only~15% are able to give rise to slowly proliferating cultures that can be propagated for at least four to five passages. Primary cultures may be difficult not only to establish, due to poor quality or abundance of biological material of origin, but also to maintain for a sufficient number of passages to perform complex analyses (Janik et al., 2016) .
Furthermore, MPEs contain a heterogeneous repertoire of cell types of which cancer cells represent only a small fraction because they secrete cytokines and chemokines that promote the recruitment of immunoregulatory cells, such as tumour-associated macrophages, which are the major component of MPEs and are involved in cancer progression (Li et al., 2016) . For all these reasons, it is important to subject MPE-derived cell cultures to a thorough phenotypic characterization through the evaluation of a variety of markers. To avoid selection of subpopulation of cells with particular growth advantages and which may not faithfully represent the composition of the originating tumour, it is necessary to proceed to phenotypic characterization of isolated cultures when the number of available cells is often very low (Janik et al., 2016) . Hence, there is a need to establish methods for the rapid characterization of cancer-initiating cells soon after their isolation. In this paper, we describe the use of an innovative support, CytoMatrix, for the characterization of limited amounts of cancer cells isolated from MPEs of patients with NSCLC. clinical history is reported in Table 1 . Tumour cells were isolated from MPEs as previously described (Mancini et al., 2011) . Briefly, pleural fluids (up to 1,000 ml) were obtained by thoracentesis and collected aseptically in nonheparinized bottles/tubes. After centrifugation at 1,200 rpm for 5 min at 4°C, the supernatant is decanted and the cell pellet resuspended in phosphate-buffered saline (PBS). The procedure is repeated twice and then the cell suspension layered on Oncoquick gradient (Greiner Bio-One) to partially purify tumour cells from the other MPE components. The cell suspension on the Oncoquick discontinuous gradient is then centrifuged at 800 g for 20 min at 4°C without brake. During the centrifugation step, the cells are separated according to their different buoyant densities: the denser fluid components such as erythrocytes and leucocytes migrate into the lower phase through the bottom of the tube, whereas the less-dense cell fraction, including tumour cells, is enriched at the interphase layer.
| MATERIALS AND METHODS

| MPE sample processing and cell cultures
After the harvesting and washing step, tumour cells are cultured in RPMI-1640 (Sigma, St. Louis, MO) supplemented with 10% fetal bovine serum (FBS; Sigma) to obtain 2D primary adherent cultures. The 3D spheroid cultures were obtained from adherent culture plating single cells at a clonal density in ultra-low attachment flasks (Corning, NY) and in serum-free Dulbecco's modified Eagle medium/F12 supplemented with basic fibroblast growth factor (20 ng/ml), epidermal growth factor (20 ng/ml), insulin (20 µg/ml), 0.5% glucose, heparin (5 µg/ ml; Sigma, St. Louis, MO) and B27 (Gibco, Invitrogen, Carlsbad, CA).
Established human NSCLC cell line, NCI-H460, was obtained from American Type Culture Collection (ATCC, Manassas, VA); 2D and 3D cultures were maintained as described for primary cells.
All cells were tested for mycoplasma contamination and subjected to short tandem repeat analysis by ATCC Cell Line Authentication Service. The primary antibodies used are listed in Table S1 . Images were obtained by using a light microscope (Nikon ECLIPSE 55i) equipped with a Digital Image Capture software (Leica Application Suite V4.8).
| Immunohistochemistry (IHC) and immunocytochemistry (ICC)
| Immunofluorescence (IF) analysis and optical microscopy
IF was performed on FFPE NCI-H460 cells entrapped in CytoMatrix.
After solvent dewaxing with Clearify Agent (Dako; Agilent, Santa Clara) and antigen retrieval with a citrate buffer pH 8 in an automated immunostainer (Omnis, Dako; Agilent, Santa Clara, CA) IF was performed as previously described . Briefly, cells were fixed with 10% neutral buffered formalin, incubated 5 min in glycine 0.1 M and permeabilized in 0.2% Triton-X (Sigma-Aldrich, Milan, Italy). After washing two times with PBS and blocking with 3% FBS in PBS, the cells were stained with anti-YAP/TAZ (Santa Cruz BRUSCHINI ET AL.
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Biotechnologies, Dallas, TX) antibody (1:50 dilution) and incubated at 4°C overnight. Next day, cells were washed by PBS three times to remove unbound antibodies, then secondary antibody (1:200 dilution) was added in the dark and incubated at room temperature for 1 hr. Then, cells were stained with Hoechest 33342 (1:1,000 dilution) for 5 min in the dark. IF images and morphology observations of cell lines were performed on Axiocam Camera (Zeiss), a digital camera, coupled with Zeiss Axiovert optical microscope and analysed using ZEN core software (Zeiss).
| Quantitative real-time PCR analysis
For quantitative real-time PCR (qRT-PCR), total RNA was isolated by TRIzol Reagent (Life Technologies, Gaithersburg, MD) according to the manufacturer's guidelines. RNA was reverse transcribed into cDNA using High Capacity RNA-to cDNA Kit (Applied Biosystems;
Life Technologies). The qRT-PCR was performed using SYBR green detection (Applied Biosystem; Life Technologies, Gaithersburg, MD) and the ΔΔC t method for relative quantification. The expression of Histone H3 or β-actin were used as internal control, as specified. The primers used for individual genes are listed in Table S2 . Note: Patient and tumour features. Specific mutation sites are also reported from NGS mutational analysis on both biopsy and primary cell line. Abbreviations: ALK, anaplastic lymphoma kinase; CDDP, cisplatin; CNV, copy number variants; EGFR, epidermal growth factor receptor; NGS, next-generation sequencing; PDL1, programmed death-ligand 1; PEM, pembrolizumab; ROS, reactive oxygen species; TTF-1, thyroid transcription factor-1; VAF, variant allele frequency. Assay with less than a 5% variant frequency and covered by <1,000 reads were not considered. Fusion genes were considered positive when ≥20 fusion amplicons were found. CNVs were annotated when confidence interval at 5% was ≥4 gene copies with ≤0.5 median of the absolute value of all pairwise differences quality control measure.
| Sequencing technologies
| Statistical analysis
All experiments were performed at least three times and the values were calculated as mean ± standard deviation or standard error of the mean. Differences between two groups were determined using Student's t test and p < .05 was considered statistically significant.
| RESULTS
| CytoMatrix: A support to entrap limited amounts of cytological material from MPEs
CytoMatrix is an innovative support, originally designed to permit an easy and rational management of the biological material from needle aspirates. A detailed study of different biocompatible materials characterized by ion affinity for cell samples allowed to discover that chitosan derivatives increase the effectiveness of the process of retaining cell suspensions dispensed on a synthetic porous matrix.
This study was conducted through a collaboration between the University Campus Bio-Medico of Rome and the industrial partner UCS Diagnostic S.r.l., and led to the development and joint patenting of CytoMatrix (Pub No. WO2018083616. International Application No: PCT/IB2017/056812). The powerful feature of this support is the ability to permit a rapid and reliable diagnosis even in the absence of large amounts of material. In line with this concept, we thought that CytoMatrix could be a useful tool for the cytological evaluation of tumour cells directly isolated from lung MPEs, to obtain a rapid and complete phenotypic characterization. CytoMatrix's peculiarity is to efficiently restrain small amounts of biological material inside its 3D structure. The porous support is provided into a plastic bio-cassette allowing to make easy the following steps of classical ICC technique, such as formalin fixation, paraffin inclusion and microtome cut (Figure 1a) .
In brief, a minimum of 100,000 2D adherent cells that roughly correspond to 250 3D spheroids are collected and centrifuged at 1,200 rpm for 5 min at 4°C. The supernatant is discarded and the cell pellet is resuspended in 1 ml of PBS and centrifuged at 1,200 rpm for 5 min at 4°C. After this washing step, the pellet is resuspended in a small volume of PBS (50-70 µl) and a single drop of cell suspension is laid on the matrix and trapped into its 3D structure. Then the biocassette is closed and processed according to a classical ICC protocol.
The sample is formalin-fixed, blocked in paraffin and the cell block cut using a microtome into 5 μm sections, which are then mounted onto the slides. These slides are dewaxed in xylene and rehydrated through a series of graded ethanol solutions and stained with Gill's haematoxylin and eosin (H&E), to assess the presence and the morphology of the cells. Finally, the slides are subjected to unmasking process and incubation with the primary antibodies in an automated immunostainer (see Section 2). Starting from a limited number of cells it is possible to obtain from each single CytoMatrix several slides, to perform a panel of immunostainings for various markers, which result in an accurate characterization of cells isolated from the lung MPEs (Figure 1b ).
In this context, it is important to underline the possibility to exploit the biological material trapped into CytoMatrix, also to perform molecular analyses by extraction of DNA and RNA or other investigations such as fluorescent in situ hybridization and IF, and how a single tool permits to take advantage of use of a minimal amount of precious biological material to perform a reliable diagnosis or research investigations also in the perspective of precision medicine.
| Characterization of primary cells from MPEs using CytoMatrix
We first sought to set up the CytoMatrix-based immunostaining protocol using a stable lung cancer cell line, namely NCI-H460, obtained from ATCC. In brief, NCI-H460 cells grown in 2D adherent conditions were harvested, resuspended in PBS and a drop of cellular suspension was trapped into CytoMatrix before formalin fixation and paraffin inclusion. Those samples were then evaluated for different markers by ICC. Our results, in line with ATCC data, confirmed that NCI-H460 cells are characterized by a strong, positive immunostaining for Pan-cytokeratin (PAN-CK), a blend of cytokeratins (CKs), which are well-known epithelial cell markers. Furthermore, those cells also presented positivity for vimentin, a mesenchymal marker that may be co-expressed with CKs in a wide range of carcinomas. Of note, the pan leucocyte marker CD45 was used as a negative control (Figure 2a ).
Thereafter, we decided to use CytoMatrix for the ICC characterization of primary cultures derived from MPEs of patients with NSCLC. We describe here below the characterization of cell lines isolated from MPEs of three representative cases with adenocarcinoma of the lung. Detailed information regarding patients' clinicopathological history is provided in Table 1 . To confirm the epithelial origin of the isolated cells, we performed a panel of immunostaining routinely used for distinguishing lung adenocarcinoma cells, namely thyroid transcription factor-1 (TTF-1), PAN-CK, and CK7 (Carney, Kraynie, & Roggli, 2015; Woo et al., 2017) . Also, the pan leucocyte marker CD45 was evaluated to assess the purity of cell preparations.
As shown in Figure 2b (and Figure S1) , primary cells exhibited a marked positivity for cytoplasmic PAN-CK and CK7, and a variable positivity for TTF-1 depending on the cell line. As expected, CD45 marker showed no staining in all the three cell lines. Finally, we ICC, immunocytochemistry; PAN-CK, Pancytokeratin and S1). We observed for all the three patients a complete correspondence of the results obtained with the two samples, thus confirming the sensitivity of the CytoMatrix approach and also the maintenance in our culture conditions of the phenotypic features of the original tumour. Of note, we have also observed a genotypic correspondence between pleural biopsy and low-passage culture cells from the same patients, as showed by the analysis of mutational status reported in Table 1 . It is important to point out that CytoMatrix also ensures the preservation of the cell morphology, tested by the routine H&E staining.
Overall, these results indicate that CytoMatrix constitutes a reliable support for the characterization with different cellular markers of primary cultures through ICC, taking advantages of using minimum amount of precious biological material compared with the classical approaches.
| CytoMatrix for the study of MPE-derived CSCs
Having documented the potential of CytoMatrix in the characterization of 2D adherent cell cultures established from MPEs of lung adenocarcinoma and given the evidence that MPEs represent an excellent model to isolate putative CSCs (Giarnieri et al., 2013; Mancini et al., 2011; Roscilli et al., 2016) , we decided to evaluate whether CytoMatrix was a useful tool for the study of this subpopulation of cells. To test this hypothesis, we first set the conditions to enrich the cell population with stem-like properties.
When cultured in nonadherent conditions and in a serum-free medium supplemented with growth factors, BBIRE-T238 and BBIRE-T248
MPE-derived primary cell lines were able to give rise to 3D spheroids at variable efficiency. On average, 3D cultures were characterized by an enrichment of stem cell markers such as nanog, sox2 and oct4. The 3D spheroids from the stable lung cancer cell line, NCI-H460, previously characterized Pisanu et al., 2017) , were used as control (Figures 3a, b and S2a, b) .
The 3D primary spheroids were then subjected to the same phenotypic characterization performed on 2D adherent cells using CytoMatrix-based immunostaining. First, H&E counterstains showed the power of this tool to preserve the 3D structure of the spheroids.
Moreover, when compared with either 2D adherent culture and the solid biopsy from the same patient, the 3D spheroid culture showed the same pattern of expression for the markers evaluated (Figures 3c and S2c) .
Recently, we and others have underlined the importance of lipid metabolism in controlling CSC maintenance (Igal, 2016; Li et al., 2017; Mancini et al., 2018) . In line with previous studies where we demonstrated that SCD1 is a key factor for the propagation of lung CSCs (Mancini et al., 2011; Noto et al., 2013 Noto et al., , 2017 Pisanu et al., 2017) , we confirm here that 3D spheroids from both the NCI-H460
NSCLC stable cell line and the BBIRE-T238 primary culture show increased expression of SCD1 at mRNA level (Figure 3b ). Furthermore, SCD1 expression was also assessed by performing CytoMatrix ICC analyses. As shown in Figure 3d , SCD1 staining shows increased expression of the protein in 3D spheroids compared with 2D adherent cell cultures. We also observed that SCD1 staining on MPE-derived primary cultures is comparable with that obtained in the solid biopsy from the same patient, confirming that cancer cells isolated from MPEs maintain in our culture conditions the expression of SCD1 found in the primary tumour (Figures 3d and S2d) . When we performed the same evaluation on 3D versus 2D cultures from BBIRE-T248, we did not observe upregulation in the expression of SCD1 at the mRNA level ( Figure S2b) as well as at the protein level ( Figure S2d ). This is probably due to patient heterogeneity as also stated by a very recent evidence that some cancer cell lines may activate an alternative fatty acid desaturation pathway to bypass the known pathway that is dependent on SCD1 (Vriens et al., 2019) .
SCD1 expression was previously shown by our group to correlate with YAP/TAZ nuclear localization among different human lung adenocarcinoma samples . When we evaluated the expression of YAP/TAZ in BBIRE-T238 and in BBIRE-T248 patient biopsies, we observed that their subcellular localization is heterogeneous, and that only in some cells it is possible to detect a strong nuclear localization (Figure 3e , upper panels and Figure S2e , upper panels). As many evidence point to YAP/TAZ as key regulators of CSCs (Cordenonsi et al., 2011; Hao et al., 2014; Hayashi et al., 2015) , Overall, these results underscore that CytoMatrix could be a useful tool not only for the phenotypic characterization of putative primary cancer cells isolated from lung MPEs but also for study of the key factors involved in the maintenance of stem-like properties in 3D spheroids.
| DISCUSSION
In this paper, we report the use of CytoMatrix, a porous support for trapping minimal amounts of cells, which allows cell fixation, slice 
